204 related articles for article (PubMed ID: 23193190)
1. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant.
Zheng P; Kissler S
Diabetes; 2013 Mar; 62(3):896-904. PubMed ID: 23193190
[TBL] [Abstract][Full Text] [Related]
2. Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice.
Fraser HI; Howlett S; Clark J; Rainbow DB; Stanford SM; Wu DJ; Hsieh YW; Maine CJ; Christensen M; Kuchroo V; Sherman LA; Podolin PL; Todd JA; Steward CA; Peterson LB; Bottini N; Wicker LS
J Immunol; 2015 Nov; 195(10):4841-52. PubMed ID: 26438525
[TBL] [Abstract][Full Text] [Related]
3. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice.
Yeh LT; Miaw SC; Lin MH; Chou FC; Shieh SJ; Chuang YP; Lin SH; Chang DM; Sytwu HK
J Immunol; 2013 Jul; 191(2):594-607. PubMed ID: 23752610
[TBL] [Abstract][Full Text] [Related]
4. PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells.
Maine CJ; Marquardt K; Cheung J; Sherman LA
J Immunol; 2014 Feb; 192(4):1415-24. PubMed ID: 24453256
[TBL] [Abstract][Full Text] [Related]
5. A functional polymorphism of Ptpn22 is associated with type 1 diabetes in the BioBreeding rat.
Sarmiento J; Wallis RH; Ning T; Marandi L; Chao G; Veillette A; Lernmark Å; Paterson AD; Poussier P
J Immunol; 2015 Jan; 194(2):615-29. PubMed ID: 25505293
[TBL] [Abstract][Full Text] [Related]
6. PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody Lymphodepletion.
Knipper JA; Wright D; Cope AP; Malissen B; Zamoyska R
Front Immunol; 2020; 11():52. PubMed ID: 32047502
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells.
Wu DJ; Zhou W; Enouz S; Orrú V; Stanford SM; Maine CJ; Rapini N; Sawatzke K; Engel I; Fiorillo E; Sherman LA; Kronenberg M; Zehn D; Peterson E; Bottini N
PLoS One; 2014; 9(2):e86677. PubMed ID: 24498279
[TBL] [Abstract][Full Text] [Related]
8. PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner.
Fousteri G; Jofra T; Di Fonte R; Kuka M; Iannacone M; Battaglia M
Clin Immunol; 2015 Feb; 156(2):98-108. PubMed ID: 25513733
[TBL] [Abstract][Full Text] [Related]
9. Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.
Perri V; Pellegrino M; Ceccacci F; Scipioni A; Petrini S; Gianchecchi E; Lo Russo A; De Santis S; Mancini G; Fierabracci A
PLoS One; 2017; 12(4):e0175784. PubMed ID: 28437437
[TBL] [Abstract][Full Text] [Related]
10. Regulation of B cell homeostasis by Ptpn22 contributes to type 1 diabetes in NOD mice.
Shi X; Shao F; Li Z; Kang L; Liu J; Kissler S; Zhou Z; Jia L; Zheng P
Endocrine; 2020 Mar; 67(3):535-543. PubMed ID: 31732921
[TBL] [Abstract][Full Text] [Related]
11. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.
Gianchecchi E; Palombi M; Fierabracci A
Autoimmun Rev; 2013 May; 12(7):717-25. PubMed ID: 23261816
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22).
Chew GY; Sinha U; Gatenby PA; DeMalmanche T; Adelstein S; Garsia R; Hissaria P; French MA; Wilson A; Whittle B; Kirkpatrick P; Riminton DS; Fulcher DA; Cook MC
J Allergy Clin Immunol; 2013 Apr; 131(4):1130-5, 1135.e1. PubMed ID: 22857794
[TBL] [Abstract][Full Text] [Related]
13. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
Menard L; Saadoun D; Isnardi I; Ng YS; Meyers G; Massad C; Price C; Abraham C; Motaghedi R; Buckner JH; Gregersen PK; Meffre E
J Clin Invest; 2011 Sep; 121(9):3635-44. PubMed ID: 21804190
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-Mediated Modification of the NOD Mouse Genome With Ptpn22R619W Mutation Increases Autoimmune Diabetes.
Lin X; Pelletier S; Gingras S; Rigaud S; Maine CJ; Marquardt K; Dai YD; Sauer K; Rodriguez AR; Martin G; Kupriyanov S; Jiang L; Yu L; Green DR; Sherman LA
Diabetes; 2016 Aug; 65(8):2134-8. PubMed ID: 27207523
[TBL] [Abstract][Full Text] [Related]
15. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.
Dai X; James RG; Habib T; Singh S; Jackson S; Khim S; Moon RT; Liggitt D; Wolf-Yadlin A; Buckner JH; Rawlings DJ
J Clin Invest; 2013 May; 123(5):2024-36. PubMed ID: 23619366
[TBL] [Abstract][Full Text] [Related]
16. B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells.
Lin MH; Chou FC; Yeh LT; Fu SH; Chiou HY; Lin KI; Chang DM; Sytwu HK
Diabetologia; 2013 Jan; 56(1):136-46. PubMed ID: 23052053
[TBL] [Abstract][Full Text] [Related]
17. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes.
Hermann R; Lipponen K; Kiviniemi M; Kakko T; Veijola R; Simell O; Knip M; Ilonen J
Diabetologia; 2006 Jun; 49(6):1198-208. PubMed ID: 16614815
[TBL] [Abstract][Full Text] [Related]
18. Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2.
Bray C; Wright D; Haupt S; Thomas S; Stauss H; Zamoyska R
Front Immunol; 2018; 9():2595. PubMed ID: 30483260
[TBL] [Abstract][Full Text] [Related]
19. Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesis.
Gianchecchi E; Crinò A; Giorda E; Luciano R; Perri V; Russo AL; Cappa M; Rosado MM; Fierabracci A
PLoS One; 2014; 9(10):e110755. PubMed ID: 25333705
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
